Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2296 AL 2310

Brain Disorder Detection and Diagnosis using Machine Learning and Deep Learning - A Bibliometric Analysis

Chaki J, Deshpande G.

Curr Neuropharmacol. 2024;22(13):2191-2216. doi: 10.2174/1570159X22999240531160344.

Acoustic assessment in mandarin-speaking Parkinson's disease patients and disease progression monitoring and brain impairment within the speech subsystem

Diao Y, Xie H, Wang Y, Zhao B, Yang A, Hlavnicka J, Zhang J.

NPJ Parkinsons Dis. 2024 Jun 12;10(1):115. doi: 10.1038/s41531-024-00720-3.

Pharmacological effects of Astragalus polysaccharides in treating neurodegenerative diseases

Shi Y, Ma P.

Front Pharmacol. 2024 Aug 2;15:1449101. doi: 10.3389/fphar.2024.1449101. eCollection 2024.

The potential of arts therapies in Parkinson's disease rehabilitation: A comprehensive review

Li Y, Luo X, Zhang A, Ying F, Wang J, Huang G.

Heliyon. 2024 Aug 3;10(16):e35765. doi: 10.1016/j.heliyon.2024.e35765. eCollection 2024 Aug 30.

Metabolomic and Lipidomic Analysis of Manganese-Associated Parkinsonism: a Case-Control Study in Brescia, Italy

Lewis F, Shoieb D, Azmoun S, Colicino E, Jin Y, Chi J, Gu H, Placidi D, Padovani A, Pilotto A, Pepe F, Turla M, Crippa P, Wang X, Lucchini RG.

medRxiv [Preprint]. 2024 Sep 6:2024.09.04.24313002. doi: 10.1101/2024.09.04.24313002.

Surgical Advances in Parkinson's Disease

Hvingelby VS, Pavese N.

Curr Neuropharmacol. 2024;22(6):1033-1046. doi: 10.2174/1570159X21666221121094343.

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders

Cohen J, Mathew A, Dourvetakis KD, Sanchez-Guerrero E, Pangeni RP, Gurusamy N, Aenlle KK, Ravindran G, Twahir A, Isler D, Sosa-Garcia SR, Llizo A, Bested AC, Theoharides TC, Klimas NG, Kempuraj D.

Cells. 2024 Mar 14;13(6):511. doi: 10.3390/cells13060511.

Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses

Park TY, Jeon J, Cha Y, Kim KS.

Cell Res. 2024 Jul;34(7):479-492. doi: 10.1038/s41422-024-00971-y. Epub 2024 May 22.

Dopaminergic neuron metabolism: relevance for understanding Parkinson's disease

Flores-Ponce X, Velasco I.

Metabolomics. 2024 Oct 13;20(6):116. doi: 10.1007/s11306-024-02181-4.

Epidemiologic and clinical features of multisystem atrophy: a population-based study in Navarre, Spain

Erro ME, Arrondo P, Gastón I, Clavero P, de Gordoa JSR, Martí Andrés G, Valentí R, Delfrade J, Vicente E.

J Neurol. 2024 Oct;271(10):6647-6654. doi: 10.1007/s00415-024-12561-4. Epub 2024 Aug 13.

Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?

Del Giudice KP, Cosgaya M, Zaro I, Ravasi V, Santacruz P, Painous C, Fernández M, Cámara A, Compta Y.

Parkinsonism Relat Disord. 2024 May;122:106080. doi: 10.1016/j.parkreldis.2024.106080. Epub 2024 Mar 8.

Mycobacterium paratuberculosis: A HERV Turn-On for Autoimmunity, Neurodegeneration, and Cancer?

Dow CT, Pierce ES, Sechi LA.

Microorganisms. 2024 Sep 13;12(9):1890. doi: 10.3390/microorganisms12091890.

Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia

Akif A, My Nguyen TT, Liu L, Xu X, Kulkarni A, Jiang J, Zhang Y, Hao J.

Res Sq [Preprint]. 2024 Dec 20:rs.3.rs-5611378. doi: 10.21203/rs.3.rs-5611378/v1.

Recent Advancements and SAR Studies of Synthetic Coumarins as MAO-B Inhibitors: An Updated Review

Kaur P, Rangra NK.

Mini Rev Med Chem. 2024;24(20):1834-1846. doi: 10.2174/0113895575290599240503080025.

[Multidisciplinary Complex Treatment of Parkinson's disease : Cornerstone of an individualized treatment]

Scherbaum R, Tönges L.

Nervenarzt. 2024 Aug;95(8):704-713. doi: 10.1007/s00115-024-01666-w. Epub 2024 May 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias